| UniProt ID | IPRI_HUMAN | |
|---|---|---|
| UniProt AC | Q8IWB1 | |
| Protein Name | Inositol 1,4,5-trisphosphate receptor-interacting protein | |
| Gene Name | ITPRIP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 547 | |
| Subcellular Localization | Cell membrane . | |
| Protein Description | Enhances Ca(2+)-mediated inhibition of inositol 1,4,5-triphosphate receptor (ITPR) Ca(2+) release.. | |
| Protein Sequence | MAMGLFRVCLVVVTAIINHPLLFPRENATVPENEEEIIRKMQAHQEKLQLEQLRLEEEVARLAAEKEALEQVAEEGRQQNETRVAWDLWSTLCMILFLMIEVWRQDHQEGPSPECLGGEEDELPGLGGAPLQGLTLPNKATLGHFYERCIRGATADAARTREFLEGFVDDLLEALRSLCNRDTDMEVEDFIGVDSMYENWQVDRPLLCHLFVPFTPPEPYRFHPELWCSGRSVPLDRQGYGQIKVVRADGDTLSCICGKTKLGEDMLCLLHGRNSMAPPCGDMENLLCATDSLYLDTMQVMKWFQTALTRAWKGIAHKYEFDLAFGQLDSPGSLKIKFRSGKFMPFNLIPVIQCDDSDLYFVSHLPREPSEGTPASSTDWLLSFAVYERHFLRTTLKALPEGACHLSCLQIASFLLSKQSRLTGPSGLSSYHLKTALLHLLLLRQAADWKAGQLDARLHELLCFLEKSLLQKKLHHFFIGNRKVPEAMGLPEAVLRAEPLNLFRPFVLQRSLYRKTLDSFYEMLKNAPALISEYSLHVPSDQPTPKS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 27 | N-linked_Glycosylation | PLLFPRENATVPENE CCCCCCCCCCCCCCH | 42.04 | UniProtKB CARBOHYD | |
| 47 | Ubiquitination | KMQAHQEKLQLEQLR HHHHHHHHHHHHHHH | 34.66 | 29967540 | |
| 66 | Ubiquitination | VARLAAEKEALEQVA HHHHHHHHHHHHHHH | 43.49 | 21963094 | |
| 66 | 2-Hydroxyisobutyrylation | VARLAAEKEALEQVA HHHHHHHHHHHHHHH | 43.49 | - | |
| 71 | Ubiquitination | AEKEALEQVAEEGRQ HHHHHHHHHHHHHHH | 40.34 | 21963094 | |
| 80 | N-linked_Glycosylation | AEEGRQQNETRVAWD HHHHHHHCHHHHHHH | 44.24 | UniProtKB CARBOHYD | |
| 141 | Phosphorylation | LTLPNKATLGHFYER CCCCCCCCHHHHHHH | 34.58 | - | |
| 244 | Ubiquitination | RQGYGQIKVVRADGD CCCCCEEEEEECCCC | 27.13 | - | |
| 252 | Phosphorylation | VVRADGDTLSCICGK EEECCCCEEEEECCC | 26.54 | 21712546 | |
| 259 | Ubiquitination | TLSCICGKTKLGEDM EEEEECCCCCCCCCE | 37.77 | 21963094 | |
| 260 | Phosphorylation | LSCICGKTKLGEDML EEEECCCCCCCCCEE | 19.45 | 24532841 | |
| 261 | Ubiquitination | SCICGKTKLGEDMLC EEECCCCCCCCCEEH | 58.96 | 21963094 | |
| 264 | Ubiquitination | CGKTKLGEDMLCLLH CCCCCCCCCEEHHHH | 51.16 | 21963094 | |
| 266 | Ubiquitination | KTKLGEDMLCLLHGR CCCCCCCEEHHHHCC | 2.18 | 21963094 | |
| 335 | Ubiquitination | LDSPGSLKIKFRSGK CCCCCCEEEEECCCC | 45.61 | 21963094 | |
| 340 | Ubiquitination | SLKIKFRSGKFMPFN CEEEEECCCCCCCCC | 49.85 | 21963094 | |
| 397 | Ubiquitination | HFLRTTLKALPEGAC HHHHHHHHHCCCCCH | 45.87 | 21963094 | |
| 402 | Ubiquitination | TLKALPEGACHLSCL HHHHCCCCCHHHHHH | 31.40 | 21963094 | |
| 407 | Phosphorylation | PEGACHLSCLQIASF CCCCHHHHHHHHHHH | 6.79 | - | |
| 417 | Phosphorylation | QIASFLLSKQSRLTG HHHHHHHHCCCCCCC | 30.69 | - | |
| 429 | Phosphorylation | LTGPSGLSSYHLKTA CCCCCCCCHHHHHHH | 32.17 | 24719451 | |
| 434 | Ubiquitination | GLSSYHLKTALLHLL CCCHHHHHHHHHHHH | 20.59 | 23503661 | |
| 439 | Ubiquitination | HLKTALLHLLLLRQA HHHHHHHHHHHHHHH | 18.45 | 23503661 | |
| 450 | Ubiquitination | LRQAADWKAGQLDAR HHHHCCHHCCHHHHH | 43.09 | 21963094 | |
| 455 | Ubiquitination | DWKAGQLDARLHELL CHHCCHHHHHHHHHH | 23.04 | 21963094 | |
| 467 | Ubiquitination | ELLCFLEKSLLQKKL HHHHHHHHHHHHHHC | 48.85 | 21963094 | |
| 472 | Ubiquitination | LEKSLLQKKLHHFFI HHHHHHHHHCCHHHC | 58.22 | 21963094 | |
| 473 | Ubiquitination | EKSLLQKKLHHFFIG HHHHHHHHCCHHHCC | 39.84 | 29967540 | |
| 515 | Ubiquitination | LQRSLYRKTLDSFYE HCHHHHHHHHHHHHH | 39.62 | - | |
| 525 | Ubiquitination | DSFYEMLKNAPALIS HHHHHHHHCCCHHHH | 50.15 | 29967540 | |
| 534 | Phosphorylation | APALISEYSLHVPSD CCHHHHEEEECCCCC | 15.11 | 27642862 | |
| 540 | Phosphorylation | EYSLHVPSDQPTPKS EEEECCCCCCCCCCC | 48.03 | 21712546 | |
| 544 | Phosphorylation | HVPSDQPTPKS---- CCCCCCCCCCC---- | 37.40 | 25159151 | |
| 546 | Ubiquitination | PSDQPTPKS------ CCCCCCCCC------ | 71.87 | 21963094 | |
| 547 | Phosphorylation | SDQPTPKS------- CCCCCCCC------- | 46.81 | 25159151 | |
| 551 | Ubiquitination | TPKS----------- CCCC----------- | 21963094 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IPRI_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IPRI_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IPRI_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of IPRI_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-547, AND MASSSPECTROMETRY. | |